SG Americas Securities LLC bought a new stake in agilon health, inc. (NYSE:AGL – Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 23,415 shares of the company’s stock, valued at approximately $92,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Capital International Investors grew its holdings in shares of agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. AQR Capital Management LLC boosted its position in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in shares of agilon health in the first quarter worth $2,975,000. Vanguard Group Inc. increased its position in shares of agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of agilon health during the second quarter worth $1,849,000.
Analyst Ratings Changes
AGL has been the subject of several analyst reports. Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Royal Bank of Canada restated an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $8.03.
agilon health Stock Up 4.5 %
AGL opened at $2.70 on Tuesday. agilon health, inc. has a one year low of $2.58 and a one year high of $18.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $1.11 billion, a P/E ratio of -3.85 and a beta of 0.54. The business’s 50-day simple moving average is $3.58 and its 200-day simple moving average is $5.13.
agilon health (NYSE:AGL – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm’s revenue was up 38.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.04) earnings per share. Analysts anticipate that agilon health, inc. will post -0.32 EPS for the current year.
Insider Activity at agilon health
In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is owned by insiders.
agilon health Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
- Five stocks we like better than agilon health
- How is Compound Interest Calculated?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Oil Stocks to Watch Before Earnings Come Out
- 3 REITs to Buy and Hold for the Long Term
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.